Free Trial

Telix Pharmaceuticals (TLX) Competitors

Telix Pharmaceuticals logo
$10.93 +0.88 (+8.76%)
Closing price 04:00 PM Eastern
Extended Trading
$10.88 -0.05 (-0.50%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TLX vs. RDY, ASND, VTRS, ROIV, QGEN, BBIO, MRNA, ELAN, VRNA, and RVMD

Should you be buying Telix Pharmaceuticals stock or one of its competitors? The main competitors of Telix Pharmaceuticals include Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Viatris (VTRS), Roivant Sciences (ROIV), QIAGEN (QGEN), BridgeBio Pharma (BBIO), Moderna (MRNA), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry.

Telix Pharmaceuticals vs. Its Competitors

Dr. Reddy's Laboratories (NYSE:RDY) and Telix Pharmaceuticals (NASDAQ:TLX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

3.9% of Dr. Reddy's Laboratories shares are owned by institutional investors. 2.0% of Dr. Reddy's Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Dr. Reddy's Laboratories has a net margin of 16.99% compared to Telix Pharmaceuticals' net margin of 0.00%. Dr. Reddy's Laboratories' return on equity of 17.25% beat Telix Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Dr. Reddy's Laboratories16.99% 17.25% 11.63%
Telix Pharmaceuticals N/A N/A N/A

In the previous week, Telix Pharmaceuticals had 14 more articles in the media than Dr. Reddy's Laboratories. MarketBeat recorded 17 mentions for Telix Pharmaceuticals and 3 mentions for Dr. Reddy's Laboratories. Dr. Reddy's Laboratories' average media sentiment score of 1.24 beat Telix Pharmaceuticals' score of 0.10 indicating that Dr. Reddy's Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Dr. Reddy's Laboratories
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Telix Pharmaceuticals
2 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Dr. Reddy's Laboratories has higher revenue and earnings than Telix Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dr. Reddy's Laboratories$3.81B3.17$663M$0.6621.92
Telix Pharmaceuticals$637.77M5.80$32.93MN/AN/A

Dr. Reddy's Laboratories currently has a consensus target price of $16.95, suggesting a potential upside of 17.16%. Telix Pharmaceuticals has a consensus target price of $21.00, suggesting a potential upside of 92.13%. Given Telix Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Telix Pharmaceuticals is more favorable than Dr. Reddy's Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dr. Reddy's Laboratories
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.80
Telix Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

Dr. Reddy's Laboratories beats Telix Pharmaceuticals on 9 of the 14 factors compared between the two stocks.

Get Telix Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLX vs. The Competition

MetricTelix PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$3.70B$3.13B$5.73B$10.43B
Dividend YieldN/A2.36%5.61%4.58%
P/E RatioN/A21.0476.4226.62
Price / Sales5.80448.77551.00126.98
Price / Cash87.4044.8325.8131.15
Price / Book9.769.7813.626.47
Net Income$32.93M-$52.73M$3.29B$271.57M
7 Day Performance16.03%2.40%1.67%2.83%
1 Month Performance-12.42%4.69%4.04%7.27%
1 Year PerformanceN/A16.28%80.70%26.07%

Telix Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLX
Telix Pharmaceuticals
3.7657 of 5 stars
$10.93
+8.8%
$21.00
+92.1%
N/A$3.70B$637.77M0.00N/AAnalyst Forecast
Gap Up
High Trading Volume
RDY
Dr. Reddy's Laboratories
2.7533 of 5 stars
$14.59
-1.9%
$16.95
+16.2%
-7.1%$12.42B$3.81B22.1127,811Positive News
ASND
Ascendis Pharma A/S
2.9954 of 5 stars
$196.42
-0.6%
$244.36
+24.4%
+29.9%$12.18B$393.54M-38.071,017High Trading Volume
VTRS
Viatris
1.2962 of 5 stars
$9.79
-1.1%
$10.40
+6.2%
-14.0%$11.54B$14.74B-3.3832,000
ROIV
Roivant Sciences
3.439 of 5 stars
$14.94
-0.7%
$19.94
+33.5%
+24.8%$10.27B$29.05M-21.34860Positive News
Analyst Revision
QGEN
QIAGEN
4.3738 of 5 stars
$45.72
-0.5%
$49.69
+8.7%
+4.7%$10.21B$1.98B27.015,765
BBIO
BridgeBio Pharma
4.5043 of 5 stars
$51.54
-1.6%
$63.94
+24.1%
+92.7%$10.01B$221.90M-12.60400
MRNA
Moderna
4.4633 of 5 stars
$26.56
+5.2%
$41.81
+57.4%
-59.6%$9.82B$3.24B-3.535,800Trending News
ELAN
Elanco Animal Health
2.6079 of 5 stars
$19.08
-0.6%
$17.33
-9.2%
+35.6%$9.54B$4.44B22.199,000Positive News
VRNA
Verona Pharma PLC American Depositary Share
2.0446 of 5 stars
$106.25
+0.2%
$109.00
+2.6%
+254.3%$9.14B$42.28M-107.3230Positive News
RVMD
Revolution Medicines
4.2996 of 5 stars
$44.41
+2.0%
$73.67
+65.9%
-2.2%$8.14B$11.58M-9.87250

Related Companies and Tools


This page (NASDAQ:TLX) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners